ReachMD
CME/CE
Your professional development is critical to the care of your patients. Stay on top of the latest treatments and information with ReachMD's CME activities. Our topics span cardiology, diabetes, oncology, women's health and more. And our CME library is continuously growing, every quarter.
Visita il sito del podcast e sostieni chi lo crea: reachmd.com
Dove ascoltare?
I podcast nell'app Replaio Radio In arrivoI podcast stanno per arrivare nell'app. Installala ora e scopri per primo un modo tutto nuovo di vivere i podcast
Episodi
Optimizing Care of the Hospitalized Patient With Overt Hepatic Encephalopathy 11.12.2025 5:15
Faculty: Nancy S. Reau, MD T his series of brief episodes focuses on the early recognition and clinical management of hepatic encephalopathy (HE). Drs. Arun Jesudian and Nancy Reau examine subtle signs that may indicate minimal or covert HE and offer strategies for timely diagnosis. The discussion covers practical tools for detection, the role of nutrition and pharmacologic therapy, and evidence-b...
Treatment of Hepatic Encephalopathy: Primary vs Secondary Prophylaxis 11.12.2025 5:15
Faculty: Arun B. Jesudian, MD Faculty: Nancy S. Reau, MD T his series of brief episodes focuses on the early recognition and clinical management of hepatic encephalopathy (HE). Drs. Arun Jesudian and Nancy Reau examine subtle signs that may indicate minimal or covert HE and offer strategies for timely diagnosis. The discussion covers practical tools for detection, the role of nutrition and pharmac...
Treatment of Hepatic Encephalopathy: When, What, How, and Why? 11.12.2025 5:00
Faculty: Arun B. Jesudian, MD T his series of brief episodes focuses on the early recognition and clinical management of hepatic encephalopathy (HE). Drs. Arun Jesudian and Nancy Reau examine subtle signs that may indicate minimal or covert HE and offer strategies for timely diagnosis. The discussion covers practical tools for detection, the role of nutrition and pharmacologic therapy, and evidenc...
The Slippery Slope of Overt Hepatic Encephalopathy 11.12.2025 4:30
Faculty: Arun B. Jesudian, MD Faculty: Nancy S. Reau, MD T his series of brief episodes focuses on the early recognition and clinical management of hepatic encephalopathy (HE). Drs. Arun Jesudian and Nancy Reau examine subtle signs that may indicate minimal or covert HE and offer strategies for timely diagnosis. The discussion covers practical tools for detection, the role of nutrition and pharmac...
Minimal Hepatic Encephalopathy: A Covert Operation? 11.12.2025 5:00
Faculty: Nancy S. Reau, MD T his series of brief episodes focuses on the early recognition and clinical management of hepatic encephalopathy (HE). Drs. Arun Jesudian and Nancy Reau examine subtle signs that may indicate minimal or covert HE and offer strategies for timely diagnosis. The discussion covers practical tools for detection, the role of nutrition and pharmacologic therapy, and evidence-b...
Minimal Hepatic Encephalopathy: Hiding in Plain Sight? 11.12.2025 5:00
Faculty: Arun B. Jesudian, MD Faculty: Nancy S. Reau, MD T his series of brief episodes focuses on the early recognition and clinical management of hepatic encephalopathy (HE). Drs. Arun Jesudian and Nancy Reau examine subtle signs that may indicate minimal or covert HE and offer strategies for timely diagnosis. The discussion covers practical tools for detection, the role of nutrition and pharmac...
Hepatic Encephalopathy: More Common Than You Think 11.12.2025 5:00
Faculty: Arun B. Jesudian, MD T his series of brief episodes focuses on the early recognition and clinical management of hepatic encephalopathy (HE). Drs. Arun Jesudian and Nancy Reau examine subtle signs that may indicate minimal or covert HE and offer strategies for timely diagnosis. The discussion covers practical tools for detection, the role of nutrition and pharmacologic therapy, and evidenc...
Advances in the Treatment of Overt Hepatic Encephalopathy: What's in the Pipeline? 11.12.2025 5:00
Faculty: Arun B. Jesudian, MD Faculty: Nancy S. Reau, MD T his series of brief episodes focuses on the early recognition and clinical management of hepatic encephalopathy (HE). Drs. Arun Jesudian and Nancy Reau examine subtle signs that may indicate minimal or covert HE and offer strategies for timely diagnosis. The discussion covers practical tools for detection, the role of nutrition and pharmac...
Current Treatment of Hepatic Encephalopathy: Is It Meeting Our Patients' Needs? 11.12.2025 4:45
Faculty: Arun B. Jesudian, MD T his series of brief episodes focuses on the early recognition and clinical management of hepatic encephalopathy (HE). Drs. Arun Jesudian and Nancy Reau examine subtle signs that may indicate minimal or covert HE and offer strategies for timely diagnosis. The discussion covers practical tools for detection, the role of nutrition and pharmacologic therapy, and evidenc...
Optimizing Care of the Hospitalized Patient With Overt Hepatic Encephalopathy 11.12.2025 5:15
Faculty: Nancy S. Reau, MD T his series of brief episodes focuses on the early recognition and clinical management of hepatic encephalopathy (HE). Drs. Arun Jesudian and Nancy Reau examine subtle signs that may indicate minimal or covert HE and offer strategies for timely diagnosis. The discussion covers practical tools for detection, the role of nutrition and pharmacologic therapy, and evidence-b...
Treatment of Hepatic Encephalopathy: Primary vs Secondary Prophylaxis 11.12.2025 5:15
Faculty: Arun B. Jesudian, MD Faculty: Nancy S. Reau, MD T his series of brief episodes focuses on the early recognition and clinical management of hepatic encephalopathy (HE). Drs. Arun Jesudian and Nancy Reau examine subtle signs that may indicate minimal or covert HE and offer strategies for timely diagnosis. The discussion covers practical tools for detection, the role of nutrition and pharmac...
Treatment of Hepatic Encephalopathy: When, What, How, and Why? 11.12.2025 5:00
Faculty: Arun B. Jesudian, MD T his series of brief episodes focuses on the early recognition and clinical management of hepatic encephalopathy (HE). Drs. Arun Jesudian and Nancy Reau examine subtle signs that may indicate minimal or covert HE and offer strategies for timely diagnosis. The discussion covers practical tools for detection, the role of nutrition and pharmacologic therapy, and evidenc...
The Slippery Slope of Overt Hepatic Encephalopathy 11.12.2025 4:30
Faculty: Arun B. Jesudian, MD Faculty: Nancy S. Reau, MD T his series of brief episodes focuses on the early recognition and clinical management of hepatic encephalopathy (HE). Drs. Arun Jesudian and Nancy Reau examine subtle signs that may indicate minimal or covert HE and offer strategies for timely diagnosis. The discussion covers practical tools for detection, the role of nutrition and pharmac...
Minimal Hepatic Encephalopathy: A Covert Operation? 11.12.2025 5:00
Faculty: Nancy S. Reau, MD T his series of brief episodes focuses on the early recognition and clinical management of hepatic encephalopathy (HE). Drs. Arun Jesudian and Nancy Reau examine subtle signs that may indicate minimal or covert HE and offer strategies for timely diagnosis. The discussion covers practical tools for detection, the role of nutrition and pharmacologic therapy, and evidence-b...
Minimal Hepatic Encephalopathy: Hiding in Plain Sight? 11.12.2025 5:00
Faculty: Arun B. Jesudian, MD Faculty: Nancy S. Reau, MD T his series of brief episodes focuses on the early recognition and clinical management of hepatic encephalopathy (HE). Drs. Arun Jesudian and Nancy Reau examine subtle signs that may indicate minimal or covert HE and offer strategies for timely diagnosis. The discussion covers practical tools for detection, the role of nutrition and pharmac...
Hepatic Encephalopathy: More Common Than You Think 11.12.2025 5:00
Faculty: Arun B. Jesudian, MD T his series of brief episodes focuses on the early recognition and clinical management of hepatic encephalopathy (HE). Drs. Arun Jesudian and Nancy Reau examine subtle signs that may indicate minimal or covert HE and offer strategies for timely diagnosis. The discussion covers practical tools for detection, the role of nutrition and pharmacologic therapy, and evidenc...
Advances in Treatment of Hypoparathyroidism: Importance of Genetic Testing for Autosomal Dominant Hypocalcemia Type 1 10.12.2025 22:30
Faculty: Michael Collins This CME activity focuses on enhancing clinician recognition and management of autosomal dominant hypocalcemia type 1 (ADH1). Learners will explore the pathophysiology and clinical manifestations of ADH1, understand barriers to timely diagnosis, gain practical strategies for implementing and interpreting genetic testing, and evaluate emerging therapies—such as calcilytics—...
Advances in Treatment of Hypoparathyroidism: Importance of Genetic Testing for Autosomal Dominant Hypocalcemia Type 1 10.12.2025 22:30
Faculty: Michael Collins This CME activity focuses on enhancing clinician recognition and management of autosomal dominant hypocalcemia type 1 (ADH1). Learners will explore the pathophysiology and clinical manifestations of ADH1, understand barriers to timely diagnosis, gain practical strategies for implementing and interpreting genetic testing, and evaluate emerging therapies—such as calcilytics—...
Taking Action Against RSV: No Child Unprotected 04.12.2025 31:00
Faculty: Tina Q. Tan, MD Faculty: Yvonne Maldonado, MD This three-part educational activity reviews the burden of respiratory syncytial virus (RSV) and evidence-based strategies to prevent disease in infants and young children. Chapter 1 examines the epidemiology of RSV and outlines current prophylactic options, including maternal vaccination and the monoclonal antibodies nirsevimab (approved 2023...
Taking Action Against RSV: No Child Unprotected 04.12.2025 31:00
Faculty: Tina Q. Tan, MD Faculty: Yvonne Maldonado, MD This three-part educational activity reviews the burden of respiratory syncytial virus (RSV) and evidence-based strategies to prevent disease in infants and young children. Chapter 1 examines the epidemiology of RSV and outlines current prophylactic options, including maternal vaccination and the monoclonal antibodies nirsevimab (approved 2023...
Early Action in Obesity: Transforming Practice, Improving Outcomes 03.12.2025 12:45
Faculty: Luca Busetto, MD Faculty: Kirsi H Pietiläinen, MD, PhD Expert faculty Drs. Luca Busetto and Kirsi H. Pietiläinen discuss the importance of early intervention in obesity management to prevent progression and obesity related complications. They examine the evolving therapeutic landscape, including GLP-1 and GIP-based medications like semaglutide and tirzepatide. The conversation highlights...
Early Action in Obesity: Transforming Practice, Improving Outcomes 03.12.2025 12:45
Faculty: Luca Busetto, MD Faculty: Kirsi H Pietiläinen, MD, PhD Expert faculty Drs. Luca Busetto and Kirsi H. Pietiläinen discuss the importance of early intervention in obesity management to prevent progression and obesity related complications. They examine the evolving therapeutic landscape, including GLP-1 and GIP-based medications like semaglutide and tirzepatide. The conversation highlights...
Future mCRC Directions: Enhancing Anti-EGFR Therapy With Novel Combination Strategies 02.12.2025 5:00
Host: Scott Kopetz, MD, PhD Host: Cathy Eng, MD, FACP This series provides expert perspectives on the management of metastatic colorectal cancer (mCRC), with a focus on the timing and methodology of molecular testing, targeted treatment combinations for BRAF-mutant mCRC, and the management of treatment-related adverse events.
Future-Proofing in HAE: Advances in Long-term Prophylaxis to Prevent Attacks and Improve Quality of Life 02.12.2025 57:15
Host: Marc A. Riedl, MD, MS On-demand webcast with expert faculty presentation on addressing the unmet needs and optimizing treatment for hereditary angioedema (HAE), including long-term prophylaxis therapy, for patients with HAE.
Rethinking Schizophrenia Treatment Through Muscarinic Modulation 02.12.2025 14:30
Faculty: Jose Rubio, MD Faculty: Jonathan M. Meyer In this Chairperson’s Perspective, Dr. Jose Rubio and Dr. Jonathan Meyer explore the evolving landscape of schizophrenia treatment through muscarinic receptor modulation. They compare the mechanisms of action, efficacy, and side effect profiles of muscarinic antipsychotics, such as xanomeline-trospium, with traditional dopamine D2 antagonists. The...
Podcast simili
Replaio non è un editore di podcast; i nomi dei programmi, le copertine e l'audio appartengono ai rispettivi autori e vengono distribuiti tramite feed RSS pubblici